BRNS — Barinthus Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Barinthus Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	214	194	142	111	70.5
Net Total Accounts Receivable
Net Total Receivables	6.95	10.4	7.94	7.14	1.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	227	213	157	126	77.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.09	15.7	19.4	11.8	5.16
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	281	270	215	160	98.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.2	12.2	12.6	15.7	10
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	28.6	27.3	27.7	30.3	24
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	252	243	187	130	74.2
Total Liabilities & Shareholders' Equity	281	270	215	160	98.2
Total Common Shares Outstanding